Press coverage about National Health Investors (NYSE:NHI) has trended somewhat positive this week, Accern Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. National Health Investors earned a news impact score of 0.22 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 46.4960586956327 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

NHI has been the subject of a number of research reports. BidaskClub upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, June 29th. Stifel Nicolaus increased their price objective on National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Wednesday, June 21st. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research note on Wednesday, May 10th. ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Finally, Mizuho restated a “neutral” rating on shares of National Health Investors in a research note on Wednesday, June 28th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $79.60.

National Health Investors (NYSE:NHI) traded up 0.34% on Friday, reaching $76.54. The company’s stock had a trading volume of 419,689 shares. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53. The firm’s 50-day moving average price is $77.38 and its 200 day moving average price is $75.03. The company has a market cap of $3.14 billion, a P/E ratio of 19.66 and a beta of 0.56.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same period last year, the company posted $1.22 earnings per share. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. Equities analysts anticipate that National Health Investors will post $3.79 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a yield of 4.96%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio (DPR) is 97.69%.

TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.